Comparing quantitative and qualitative muscle-relaxant monitoring during non-cardiothoracic surgery
Official title: Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery (The QUANTUM Trial): Single-center Cluster Randomized Multiple Crossover Trial
Run by The University of Texas Health Science Center, Houston · NCT07084363 · Data updated 2026-11-12
This study will test whether using quantitative monitors instead of cheaper qualitative checks lowers oxygenation problems after non-cardiothoracic surgery in adults given rocuronium.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1032 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | February 15, 2026 |
| Study ends | April 1, 2026 |
| Registry record updated | October 10, 2025 |
| Trial ID | NCT07084363 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) undergoing non-cardiothoracic surgery with general anesthesia, endotracheal intubation, and rocuronium who do not have pre-existing neuromuscular disease or implanted electronic devices are ideal candidates.
✕Probably not a fit
Patients intubated before induction, emergency or critically ill ICU admissions, non-intubated or non-paralyzed cases, those with implanted electronic devices, adhesive allergies, or pre-existing neuromuscular disease are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults having non-cardiothoracic surgery under general anesthesia with endotracheal intubation who receive rocuronium will be monitored for neuromuscular block using either quantitative (objective) devices or less expensive qualitative methods. The trial will compare the lowest SpO2/FiO2 ratio in the PACU between the two monitoring approaches. Outcomes will be used to inform an enhanced recovery pathway for surgical patients. The protocol excludes patients intubated before induction, emergency or critically ill ICU admissions, those not paralyzed during surgery, and people with implanted electronic devices, adhesive allergies, or pre-existing neuromuscular disease.
Why it matters
Potential benefit: If successful, quantitative monitoring could reduce postoperative oxygenation problems and help improve recovery protocols after surgery.
How similar studies have gone: Previous studies have suggested quantitative neuromuscular monitoring reduces residual blockade and pulmonary complications compared with qualitative methods, though adoption and definitive outcome data remain variable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Patient age ≥ 18 years old; * General anesthesia with endotracheal intubation; * Neuromuscular block with rocuronium. Exclusion criteria: * Intubation before induction of anesthesia; * Critically ill patients admitted from the ICU; * Emergency cases; * Non-intubated patients; * Patients who will not be paralyzed through the surgery (spine). * Patients with an implanted electronic device (e.g. cardiac pacemaker) * Patients with allergies to adhesive * Patients with pre-existing neuromuscular disease (e.g. Myasthenia Gravis)
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Mehmet Turan, MD — The University of Texas Health Science Center, Houston
- Study coordinator: Mehmet Turan, MD
- Email: Mehmet.A.Turan@uth.tmc.edu
- Phone: (713) 500-6251
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Circadian Variation of Anti-Factor Xa in Trauma Patients on LMWH
This study tests whether anti-Factor Xa levels show a daily rhythm in hospitalized trauma patients receiving LMWH for VTE prevention.
-
PrioritiesAI: A chat tool to help older adults with hernia decide what matters most for surgery
This study tests an AI-powered chat assistant to help people with hernia clearly express and communicate their health goals for elective surgery.
-
Family-based program to reduce risk factors for schizophrenia spectrum disorders in youth with family history
This study tests a brief family-based psychosocial program to see if it lowers persistent psychotic-like experiences in kids and young adults with a family history of SSD and different brain risk patterns.
-
EUS-Guided RFA for Pancreatic Lesions: Safety and Outcomes
This study tests whether using endoscopic ultrasound-guided radiofrequency ablation is safe and helps patients with pancreatic lesions.
-
Skin-to-skin care with the Skincubator for preterm infants
This study tests whether using the Skincubator during skin-to-skin care is safe and feasible for preterm babies and their parents in the NICU.
-
See if iCHAMPSS 2.0 helps schools spread effective sexual health programs
This study tests whether iCHAMPSS 2.0 helps Texas schools implement an evidence-based sexual health program more effectively for teachers, administrators, and health staff.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.